Q2 2019 Holdings
Filed 2019-08-14 | 72 holdings | $155.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $75.0M | 2,780,885 | 48.2% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $46.1M | 400,000 | 29.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $21.2M | 150,000 | 13.6% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $11.3M | 700,000 | 7.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $548.0K | 250,000 | 0.4% |
| Turning Point Therapeutics I | COM | 90041T108 | $127.1K | 3,122,367 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $113.3K | 1,100,000 | 0.1% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $78.9K | 900,000 | 0.1% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $76.1K | 806,150 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $75.2K | 2,966,108 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $67.9K | 1,550,000 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $54.5K | 1,869,680 | 0.0% |
| Axonics Modulation Tech Inc(AXNX*) | COM | 05465P101 | $51.3K | 1,252,495 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $46.9K | 600,000 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $46.5K | 1,177,975 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $45.2K | 1,361,898 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $39.5K | 700,000 | 0.0% |
| Quotient LTD | SHS | G73268107 | $35.5K | 3,800,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $34.2K | 225,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $33.0K | 350,000 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $33.0K | 700,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $31.1K | 2,074,595 | 0.0% |
| Ascendis Pharma A S(ASND)Call | SPONSORED ADR | 04351P101 | $28.8K | 250,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $28.2K | 650,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $27.6K | 1,400,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $25.1K | 500,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN)Call | COM | G11196105 | $24.1K | 550,000 | 0.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $22.9K | 1,000,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $22.6K | 175,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $22.0K | 2,365,280 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $20.8K | 450,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR)Call | COM | 60468T105 | $20.6K | 200,000 | 0.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $20.5K | 706,064 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $18.3K | 100,000 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $17.2K | 551,921 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $15.6K | 1,271,685 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $15.6K | 85,000 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $15.0K | 1,000,000 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $14.7K | 767,842 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $14.3K | 643,129 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $14.2K | 400,000 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $13.4K | 890,387 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $12.2K | 1,150,000 | 0.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $12.1K | 200,000 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $11.9K | 906,229 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $11.7K | 200,000 | 0.0% |
| Health Sciences Acqustn Corp | UNIT 04/01/2024 | 42227C201 | $11.5K | 1,080,000 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $10.5K | 350,000 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $10.5K | 300,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $10.2K | 730,325 | 0.0% |